Mecapegfilgrastim for prophylaxis of febrile neutropenia in children and adolescents with rhabdomyosarcoma or Ewing sarcoma: a prospective, single-arm, pilot study

Abstract Background The chemotherapy regimens recommended for both rhabdomyosarcoma (RMS) and Ewing sarcoma (ES) patients are myelosuppressive and can reduce the absolute neutrophil count (ANC) and subsequently increase the risk of febrile neutropenia (FN). However, only a few studies have focused o...

Description complète

Détails bibliographiques

Auteurs principaux:	Wen Zhao, Yuchen Zhou, Xisi Wang, Peiyi Yang, Cheng Huang, Xiaoli Ma, Yan Su, Rui Zhang
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2024-08-01
Collection:	BMC Cancer
Sujets:	Rhabdomyosarcoma Ewing sarcoma Febrile neutropenia Granulocyte colony-stimulating factor Pegfilgrastim
Accès en ligne:	https://doi.org/10.1186/s12885-024-12766-w
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!